Results 141 to 150 of about 95,421 (257)

Evaluation of Probiotic Properties and Antimicrobial Substances Produced by Five Lactic Acid Bacteria Against Foodborne and Spoilage Pathogens

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
ABSTRACT The rise of multidrug‐resistant (MDR) pathogens presents a major challenge to food safety, particularly in preservation approaches. Lactic acid bacteria (LAB) gain probiotic recognition by effectively controlling MDR pathogens using antimicrobial substances (AMSs) and bacteriocin‐like inhibitory substances (BLISs).
Md. Moklesur Rahman   +5 more
wiley   +1 more source

Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil

open access: yes, 2017
A total of 296 Shigella spp. were received from State Public Health Laboratories, during the period from 1999 to 2004, by National Reference Laboratory for Cholera and Enteric Diseases (NRLCED) - IOC/Fiocruz, Rio de Janeiro, Brazil.
Souza, Flávia dos Santos   +3 more
core  

Adjuvant Antibacterial Effects of Mouriri Elliptica Against Clinical Multidrug Resistant Gram‐Negative Bacterial Strains

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
The ethanolic leaf extract of Mouriri elliptica exhibited antibacterial and antibiofilm activities against multidrug‐resistant clinical isolates and enhanced the activity of ampicillin. Its diverse chemical profile and low acute toxicity support this Cerrado species as a promising source of natural antibacterial adjuvants. ABSTRACT Bacterial resistance
Talita Vilalva Freire   +9 more
wiley   +1 more source

Shigella surveillance report no. 37, March 1976

open access: yes
Third and Fourth QuartersFor the period July through December 1974, 10,193 shigella isolations from humans were reported. This represents an increase of 981 (10.6%) over the 9,212 isolations reported for the preceding 6 months and a decrease of 23 (0.2%)

core  

Molecular Diagnostics for WHO Priority Bacterial Pathogens: A Bibliometric Mapping of Diagnostic Platforms, Resistance Markers, and Antimicrobial Resistance Research Trends

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
This bibliometric mapping of 1746 publications (2000–2025) charts molecular diagnostics for WHO priority bacterial pathogens across platforms, targets, and resistance markers. Conventional PCR/NAAT and whole‐genome sequencing emerge as complementary core platforms, and the field evolves from targeted pathogen detection into an AMR‐centered ...
Selahattin Ünlü
wiley   +1 more source

Shigella surveillance report no. 33, APRIL 1973

open access: yes
Third and Fourth Quarters 1972For the period July-December 1972, 7,486 shigella isolations from humans were reported. This represents an increase of 1,174 (18.6%) over the 6,312 isolations reported for the preceding 6 months and an increase of 282 (3.9%)

core  

Phytochemical Composition and Antibacterial Activity of Medicinal Plants Against Bacterial Pathogens Isolated From Livestock Wound Infections

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
The graphical abstract visually summarizes the study's key findings: it lists the major bacterial pathogens isolated from livestock wounds (such as S. aureus and E. coli) and the medicinal plants tested (Withania somnifera, Achyranthes aspera. It highlights the phytochemicals (alkaloids, flavonoids, etc.) present in the plant extracts and shows that ...
Safia Arbab   +7 more
wiley   +1 more source

Obtención de un preparado vacunal inmunogénico y protectogénico en modelos animales a partir de aislamientos autóctonos de Shigella sonnei

open access: yes, 2017
La shigelosis constituye un problema de salud mundial, principalmente en niños menores de 5 años de edad. Dentro del género Shigella, S. sonnei es el segundo agente causal de esta enfermedad en Cuba.
Martínez Fernández, Olga María
core  

Mecillinam activity against multidrug-resistant Shigella sonnei and Shigella flexneri

open access: yes
We performed phenotypic susceptibility testing and whole-genome sequencing to investigate in vitro mecillinam activity against multidrug-resistant (MDR) Shigella.
Gordon Ritchie   +9 more
core   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

open access: yesMedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy